Biotia is a New York City-based clinical metagenomics company that pairs pathogen genomics with artificial intelligence to diagnose challenging and chronic infections. A spinout of the Jacobs Technion-Cornell Institute at Cornell Tech, it operates a high-complexity CLIA-certified laboratory and offers its flagship BIOTIA-ID Urine Test for recurrent and complicated urinary tract infections to physicians and patients in all 50 US states. Its partners and collaborators include Mayo Clinic, Hospital for Special Surgery, and NASA, and it is expanding its test menu into women's health and orthopedic diagnostics.
1
Round
1
Industry
5
Tags
Oct 1, 2026
Latest raise
Funding activity · 1 round
Oct 1, 2026
$9M
Series A
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
